Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07064421

Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy

Non-Helium Magnetoencephalography for Clinical Management of Refractory Epilepsy in Children: An Observational Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Guangzhou Women and Children's Medical Center · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to evaluate the effectiveness of Magnetoencephalography (MEG) in the preoperative assessment of children with refractory epilepsy, particularly in identifying the seizure focus, and to compare it with the gold standard methods of Stereo-electroencephalography (SEEG) and Electrocorticography (ECoG). The main questions this study aims to answer are: 1. How consistent is MEG with SEEG/ECoG in locating the epileptic focus in children with refractory epilepsy? 2. What is the clinical efficacy of MEG in identifying epileptic foci? Participants will: 1. Be divided into 2 groups: the case group and the control group. Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment, while patients in the control group will undergo only SEEG/ECoG before surgery. 2. Be followed up at 1, 3, 6, and 12 months after surgery to assess seizure control, neurological function, and quality of life.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetoencephalography plus Stereo-electroencephalography/ElectrocorticographyUse Magnetoencephalography and Stereo-electroencephalography/Electrocorticography in the preoperative assessment of children with drug-resistant epilepsy, particularly in identifying the seizure focus.
DIAGNOSTIC_TESTStereo-electroencephalography/ElectrocorticographyUse Stereo-electroencephalography/Electrocorticography in the preoperative assessment of children with drug-resistant epilepsy, particularly in identifying the seizure focus.

Timeline

Start date
2024-11-05
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2025-07-14
Last updated
2025-07-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07064421. Inclusion in this directory is not an endorsement.